Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers

Molecular Neurobiology

Volumn 52, Issue 3, 2015, Pages 1494-1503

  Zi, Ying ^a,b   Yin, Zhongmin ^b   Xiao, Weizhong ^c   Liu, Xinwei ^d   Gao, Zhixiang ^e   Jiao, Li ^e   Deng, Lianfu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b The 463 Hospital of Chinese PLA   (China)

^c FUDAN UNIVERSITY   (China)

^d GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Circulating; Meta analysis; MicroRNAs; Molecular marker; Neurodegenerative diseases

Indexed keywords

MICRORNA; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; ASSAY; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ODDS RATIO; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; MULTIPLE MIRNA ASSAY; MULTIPLE SCLEROSIS; NEGATIVE LIKELIHOOD RATIO; PARKINSON DISEASE; POSITIVE LIKELIHOOD RATIO; QUALITY CONTROL PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE MIRNA ASSAY; SYSTEMATIC REVIEW; BLOOD; CAUCASIAN; NEURODEGENERATIVE DISEASES; PREDICTIVE VALUE; PUBLISHING;

BIOMARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MICRORNAS; NEURODEGENERATIVE DISEASES; PREDICTIVE VALUE OF TESTS; PUBLICATION BIAS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84942831237     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8944-x     Document Type: Article

References (41)

1. Pillai JA, Cummings JL (2013) Clinical trials in predementia stages of Alzheimer disease. The Medical Clinics of North America 97(3):439–457. doi:10.1016/j.mcna.2013.01.002
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123(8):933–944. doi:10.1161/CIR.0b013e31820a55f5
3. Sherer TB (2011) Biomarkers for Parkinson’s disease. Sci Trans Med 3(79):79 ps14. doi:10.1126/scitranslmed.3002488
4. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384–386. doi:10.1212/01.wnl.0000247740.47667.03
5. Paraboschi EM, Solda G, Gemmati D, Orioli E, Zeri G, Benedetti MD, Salviati A, Barizzone N, Leone M, Duga S, Asselta R (2011) Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. Int J Mol Sci 12(12):8695–8712. doi:10.3390/ijms12128695
6. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517. doi:10.1016/S0140-6736(08)61620-7
7. Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, Morris JC, Holtzman DM (2009) Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type. Arch Neurol 66(5):638–645. doi:10.1001/archneurol.2009.55
8. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain: a journal of neurology 125(Pt 4):861–870
9. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework (2001). Clinical pharmacology and therapeutics 69(3):89–95. doi:10.1067/mcp.2001.113989
10. Brodersen P, Voinnet O (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10(2):141–148. doi:10.1038/nrm2619
11. Wu R, Jiang Y, Wu Q, Li Q, Cheng D, Xu L, Zhang C, Zhang M, Ye L (2014) Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies. Tumour biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2106-7
12. Li Q, Liu L, Li W (2014) Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2364-4
13. Guo Z, Zhao C, Wang Z (2014) MicroRNAs as ideal biomarkers for the diagnosis of lung cancer. Tumour biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2330-1
14. Ding Z, Wu H, Zhang J, Huang G, Ji D (2014) MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles. Tumour biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2133-4
15. Zhang Y, Zhong Q, Chen X, Fang J, Huang Z (2014) Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples. Tumour biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2209-1
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006. doi:10.1038/cr.2008.282
17. Schipper HM, Maes OC, Chertkow HM, Wang E (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regulation and Systems Biology 1:263–274
18. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A 106(31):13052–13057. doi:10.1073/pnas.0906277106
19. Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. The Journal of Biological Chemistry 285(17):12726–12734. doi:10.1074/jbc.M109.086827
20. Liu CG, Wang JL, Li L, Wang PC (2014) MicroRNA-384 regulates both amyloid precursor protein and beta-secretase expression and is a potential biomarker for Alzheimer’s disease. International Journal of Molecular Medicine 34(1):160–166. doi:10.3892/ijmm.2014.1780
21. Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MMG, Sterne JAC, Bossuyt PMM, Grp Q- (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529-U104. doi:10.1059/0003-4819-155-8-201110180-00009
22. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E (2009) Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 4(10):e7440. doi:10.1371/journal.pone.0007440
23. Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, Forsgren L, Neuman LA, Tan AC (2012) Plasma-based circulating MicroRNA biomarkers for Parkinson’s disease. Journal of Parkinson’s disease 2(4):321–331. doi:10.3233/jpd-012144
24. Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR (2012) Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging 4(9):590–605
25. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y (2013) Circulating miRNA biomarkers for Alzheimer’s disease. PLoS One 8(7):e69807. doi:10.1371/journal.pone.0069807
26. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stahler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7):R78. doi:10.1186/gb-2013-14-7-r78
27. Sheinerman KS, Tsivinsky VG, Abdullah L, Crawford F, Umansky SR (2013) Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging 5(12):925–938
28. Sondergaard HB, Hesse D, Krakauer M, Sorensen PS, Sellebjerg F (2013) Differential microRNA expression in blood in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 19(14):1849–1857. doi:10.1177/1352458513490542
29. Bhatnagar S, Chertkow H, Schipper HM, Yuan Z, Shetty V, Jenkins S, Jones T, Wang E (2014) Increased microRNA-34c abundance in Alzheimer’s disease circulating blood plasma. Front Mol Neurosci 7:2. doi:10.3389/fnmol.2014.00002
30. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. doi:10.1186/1471-2288-6-31
31. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5:24. doi:10.1186/1476-4598-5-24
32. Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T (2014) Circulating miR-125b as a biomarker of Alzheimer’s disease. J Neurol Sci 336(1–2):52–56. doi:10.1016/j.jns.2013.10.002
33. Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Decard BF, Thum T, Gold R (2012) Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 79(22):2166–2170. doi:10.1212/WNL.0b013e3182759621
34. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, Takahashi T (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96(2):111–115. doi:10.1111/j.1349-7006.2005.00015.x
35. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866. doi:10.1038/nrc1997
36. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13(4):423–433. doi:10.1038/ncb2210
37. Yang Y, Zhu R (2014) Diagnostic value of circulating microRNAs for hepatocellular carcinoma. Mol Biol Rep. doi:10.1007/s11033-014-3578-7
38. Gao Y, Zhao H, Lu Y, Li H, Yan G (2014) MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-2381-3
39. Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease. Exp Neurol 235(2):491–496. doi:10.1016/j.expneurol.2011.11.026
40. Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219–6225. doi:10.1007/s11033-011-1441-7
41. Martinez-Mesa J, Gonzalez-Chica DA, Bastos JL, Bonamigo RR, Duquia RP (2014) Sample size: how many participants do I need in my research? An Bras Dermatol 89(4):609–615